Leadership team

Dr Varun Sethi is the Acting Chief Executive Officer Clinigen, joining the company in August 2024. Varun is a seasoned healthcare executive with over 22+ years’ experience across pharmaceuticals, medical devices, and diagnostics, and has a deep understanding of the healthcare landscape in Asia Pacific. In the past year, he has led a significant turnaround of the JAPAC business, driving growth and expanding Clinigen’s market footprint.

Prior to Clinigen, Varun held senior leadership roles at DKSH, Fortis Healthcare and Baxter International. He has been a member of the boards of the Pharmaceutical Association of Malaysia (PhAMA) and Singapore Association of Pharmaceutical Companies (SAPI) where he served as Treasurer in both industry associations.

Varun holds a Ph.D. in pharmaceutical sciences from the University of Illinois, Chicago, as well as an Executive Certification in marketing and sales from the Kellogg School of Management, Northwestern University, Chicago.

Stephanie is Chief Financial Officer at Clinigen, joining the company in 2026. Stephanie brings extensive financial leadership experience, including 15 years within the pharmaceutical industry, notably at GSK. 

She has held senior finance roles across global organisations, bringing a strong track record in strategic transformation, performance delivery and leading high‑performing teams in complex, international environments. 

Stephanie combines deep sector expertise with a broad cross‑industry perspective, and is experienced in driving financial discipline, enabling growth and supporting organisational change. 

Alex Johnson is the Chief supply Chain and Transformation Officer at Clinigen, joining the company in September 2023, and is driving the company's strategic end-to-end business transformation and optimising supply chain operations across Europe, the US, and the rest of the world.  

With over 20 years of global experience in business transformation and supply chain management, Alex is a seasoned transformation and turnaround specialist, and his expertise spans operational excellence, supply chain optimisation, M&A integrations, business turnaround, digital transformation, and large-scale programme management. 

Before joining Clinigen, Alex held leadership roles at both FTSE100 and S&P500 organisations including Royal Mail, BP, and Ecolab before working on a consulting basis on a number of business turnarounds. 

Guy Strutton, MCIPD, is the Chief People Officer at Clinigen, where he has played an integral role in shaping the company's human capital strategy for over 20 years. With a deep-rooted understanding of Clinigen's culture and business objectives, Guy is instrumental in driving talent acquisition, development, and retention.

Prior to his current role, Guy held several senior HR positions at Clinigen, including EVP HR and SVP HR. His extensive experience spans various HR functions, from learning and development to global HR business partnering.

Guy holds a Bachelor of Arts in Spanish and Portuguese from the University of Leeds and a Master of Arts in Human Resources Management from Kingston University. 

Merav is a seasoned regulatory affairs professional with over 30 years of experience in the pharmaceutical industry. As Senior Vice President of Pharmacovigilance, Medical Information, and Regulatory Affairs Operations for Lifecycle Services at Clinigen, she leads a global team dedicated to ensuring patient safety and regulatory affairs strategy and submissions.

Trained as a pharmacist with a master’s degree in Biopharmacy from King’s College London, Merav brings a deep understanding of drug development and lifecycle management. Having joined Clinigen in 2014, her expertise is instrumental in guiding Clinigen’s global projects through complex regulatory landscapes.

Merav is passionate about building high-performing teams and fostering a culture of excellence. Under her leadership, the Clinigen team delivers exceptional pharmacovigilance, medical information, and regulatory support to clients worldwide.

Jose brings over a decade of experience in Clinical Services, most recently serving as General Manager - Clinical Trials, at Thermo Fisher Scientific. Earlier in his career, he held engineering leadership roles at Pratt & Whitney and Rexnord Corporation. Jose holds two master’s degrees in engineering and technology from the University of Miami and an MBA from Carnegie Mellon University.

A recognised expert in strategy and business system deployment, Jose is passionate about fostering a culture of continuous improvement. In his new role, one of his key objectives will be to enhance Operational Efficiency and help Clinigen achieve world-class customer service standards.

Tom leads our Clinical Trial Sourcing Business and has held several senior roles since joining Clinigen in 2018, including VP of Finance. Earlier in his career, Tom was Financial Controller at real estate business CBRE and also worked as a Financial Analyst at Network Rail. Tom has a BA in Business & Managerial Economics from the University of Leeds. 

Suzanne has more than 20 years industry experience and is currently SVP of Managed Access at Clinigen, having joined in January 2013.

Since joining Clinigen, Suzanne has been intricately involved in managed access programs; first setting up and running on behalf of clients and, since 2015, leading the growing Program Management function and now Business Unit and with oversight and governance responsibility across the Clinigen MAP portfolio.

Prior to joining Clinigen, Suzanne worked client side in large pharma R&D within a range of technical, leadership and project management roles. Suzanne has a PhD in Chemistry. 

Dan is SVP, Commercial at Clinigen, bringing over 25 years of leadership experience across the pharmaceutical industry. He has a strong track record of shaping commercial strategy, driving performance, and leading high‑performing teams across global markets. 

He brings deep expertise in product access, global commercial management and specialty medicine commercialisation, with experience delivering commercial growth and expanding patient access in complex environments. 

As SVP, Commercial, Dan leads Clinigen’s global commercial strategy, focused on strengthening capabilities and delivering value for partners, customers and patients worldwide. 

Kate is SVP, EU, US & ROW at Clinigen, joining the company in 2026. Kate brings 19 years of experience across biotech and pharma, with a background spanning both commercial and R&D leadership roles. 

Kate has deep expertise in CNS conditions, including pain and sleep disorders, alongside experience in osteoporosis, oncology, nephrology and supportive care. She has led cross‑functional teams and delivered commercialisation strategies from preclinical development through to launch across multiple international markets. 

She is an experienced global leader, with a strong track record in driving collaboration across R&D, commercial and partner organisations, and leading transformation initiatives that support growth and expand patient access to medicines.

Carel is a pharmacist by profession and completed his master’s degree in pharmaceutical formulations. His passion for people and assisting healthcare providers and patients to access medicines led him to join Clinigen South Africa in 2009.

He started his tenure at the African affiliate overseeing the unlicensed medicine department and established the company as the leading supplier of unlicensed medicine in South Africa. He continued his growth in the organisation and was responsible for business development in the African region. He was appointed as the managing director for the African affiliate in 2018.

In his role he oversees the African affiliate which consists of various operational entities including licensed and unlicensed pharmaceutical products and medical devices. He has successfully expanded the organisation and onboarded partnerships with principles across the globe to market and distribute their products in sub-Saharan and East Africa.